Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FG9Q3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,489
Award facts
- Contract value 100% obligated
- $12,489.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,489.29 to AmerisourceBergen Drug Corp for 300 mg/2 ml DUPIXENT pens on August 10, 2025, with completion scheduled for August 11, 2025. The award utilized firm fixed price pricing and was not designated as a set-aside contract, indicating it was competitively awarded. DUPIXENT (dupilumab) is a prescription biologic medication used to treat conditions such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal healthcare systems.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The overarching IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The delivery order reflects the company's role as a critical vendor in the federal medical procurement supply chain, providing specialty medications and biologics to support Defense Health Agency operations and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FG9Q3?
SPE2DB25FG9Q3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 10, 2025.
How much is contract SPE2DB25FG9Q3 worth?
The government has obligated $12,489 on SPE2DB25FG9Q3.
Is contract SPE2DB25FG9Q3 an order under another contract?
Yes. SPE2DB25FG9Q3 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FG9Q3 competed?
The extent of competition for SPE2DB25FG9Q3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award